Swiss National Bank - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 153 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q3 2016. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q3 2018$717,000
-2.3%
421,6500.0%0.00%0.0%
Q2 2018$734,000
-4.9%
421,6500.0%0.00%0.0%
Q1 2018$772,000
-17.9%
421,6500.0%0.00%0.0%
Q4 2017$940,000
-12.8%
421,650
+13.5%
0.00%0.0%
Q3 2017$1,078,000
-34.8%
371,6500.0%0.00%
-50.0%
Q2 2017$1,654,000
+9.2%
371,650
+14.4%
0.00%0.0%
Q1 2017$1,514,000
-14.5%
324,850
+11.7%
0.00%
-33.3%
Q4 2016$1,771,000
+10.5%
290,8500.0%0.00%0.0%
Q3 2016$1,603,000
+143.2%
290,850
+67.8%
0.00%
+200.0%
Q2 2016$659,000
+42.6%
173,3500.0%0.00%0.0%
Q1 2016$462,000
-41.1%
173,350
+25.3%
0.00%
-50.0%
Q4 2015$784,000
+17.5%
138,300
+9.9%
0.00%0.0%
Q3 2015$667,000
-24.9%
125,800
+17.6%
0.00%0.0%
Q2 2015$888,000
+95.2%
107,000
+8.7%
0.00%
+100.0%
Q1 2015$455,000
+51.7%
98,4000.0%0.00%0.0%
Q4 2014$300,000
+9.5%
98,4000.0%0.00%0.0%
Q3 2014$274,000
-31.5%
98,4000.0%0.00%0.0%
Q2 2014$400,000
-5.4%
98,400
+23.5%
0.00%
-50.0%
Q1 2014$423,000
+12.5%
79,700
+19.5%
0.00%
+100.0%
Q4 2013$376,000
+23.3%
66,7000.0%0.00%0.0%
Q3 2013$305,000
+73.3%
66,700
+63.9%
0.00%0.0%
Q2 2013$176,00040,7000.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q3 2016
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,200,000$6,072,0002.38%
GREAT POINT PARTNERS LLC 2,175,000$6,003,0002.15%
Belmont Global Advisors, Inc. 400,000$1,104,0001.12%
Trellus Management Company, LLC 162,900$450,0000.78%
PURA VIDA INVESTMENTS, LLC 572,800$1,581,0000.72%
DAFNA Capital Management LLC 294,563$813,0000.70%
Twin Securities, Inc. 1,687,115$4,656,0000.58%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 1,000,000$2,760,0000.33%
WALL STREET ASSOCIATES 269,300$743,0000.31%
Paulson & Co. 11,090,000$30,608,0000.23%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders